Wu, Sheng-Kai
Tsai, Chia-Lin
Mir, Aisha
Hynynen, Kullervo
Funding for this research was provided by:
National Institute of Biomedical Imaging and Bioengineering (R01 EB003268)
Canadian Institutes for Health Research (FRN 119312)
Article History
Received: 12 August 2024
Accepted: 6 January 2025
First Online: 15 January 2025
Declarations
:
: K.H. is a co-founder of FUS Instruments, a company that is commercializing the preclinical FUS system used in this work. S.-K. W, C.-L. T, and A. M. declare no competing interestst.